Health status function after treatment with thermal balloon endometrial ablation and levonorgestrel intrauterine system for idiopathic menorrhagia: a randomized study.

Abstract

AIM:

To compare patients' health status function after treatment with thermal balloon endometrial ablation (TBEA) and levonorgestrel intrauterine system (LNG-IUS) for idiopathic menorrhagia.

METHODS:

Forty-four patients were recruited into a randomized trial comparing their health status after treatment with TBEA or LNG-IUS for idiopathic menorrhagia.

RESULTS:

At 1 year follow-up, the mean haemoglobin was significantly higher in women treated with TBEA (12.6 g/dl vs. 10.3 g/dl, p = 0.018). Iron deficiency occurred in 13.3% from the TBEA arm and in 50% from the LNG-IUS arm (p = 0.026). The women's mean Short Form 36 Questionnaire general health perception scores (54.9 vs. 40.5, p = 0.024) and mental health scores (49.5 vs. 38.3, p = 0.021) in TBEA arm were significantly higher than in the LNG-IUS arm. The mental health domain score was also significantly lower in the LNG-IUS arm (46.1 vs. 38.3, p = 0.041).

CONCLUSION:

TBEA appears to offer better health status function at 1 year follow-up and to be more acceptable to our Chinese population in the treatment of idiopathic menorrhagia following failed medical treatment.

• Authors: Wing Hung Tam, Pong Mo Yuen, Doris Pui Shan Ng, Pui Ling Leung, Ingrid Hung Lok, Michael Scott Rogers
• Journal: Gynecologic and obstetric investigation (Gynecol Obstet Invest) Vol. 62 Issue 2 Pg. 84-8 ( 2006) ISSN: 0378-7346 [Print] Switzerland
• PMID: 16612101 (Publication Type: Journal Article, Randomized Controlled Trial)

Chemical References

• Contraceptive Agents, Female
• Hemoglobins
• Levonorgestrel

Topics

• Adult
• Catheter Ablation (adverse effects, methods)
• Catheterization (adverse effects, methods)
• Contraceptive Agents, Female (adverse effects, therapeutic use)
• Endometrium
• Female
• Follow-Up Studies
• Health Status
• Hemoglobins (metabolism)
• Humans
• Intrauterine Devices, Medicated
• Iron Deficiencies
• Levonorgestrel (adverse effects, therapeutic use)
• Menorrhagia (complications, therapy)
• Mental Health
• Patient Satisfaction
• Prospective Studies
• Quality of Life
• Surveys and Questionnaires
• Treatment Outcome